IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Hospitals and facilities in Arkansas

In 2025 Q1–Q4, the provider or facility offer prevailed in 87.8% of 7,221 determined Federal IDR dispute line items for hospitals and facilities in Arkansas. The median prevailing offer was 3.12x the QPA (25th–75th percentile 1.70x–4.78x; n = 5,004). The median time to a decision was 59 business days (n = 7,221).

Determined line items

7,221

2025 Q1–Q4 · 16 split decisions excluded

Provider win rate

87.8%

n = 7,221 · 2025 Q1–Q4

Median payment vs QPA

3.12x

middle half 1.70x–4.78x · n = 5,004 · 2025 Q1–Q4

Median days to decision

59

business days, from dispute initiation · n = 7,221 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q47,22187.8%3.12x1.70x–4.78x5,00459
2024 Q1–Q46,27281.6%2.75x1.41x–4.25x3,57793
2023 Q1–Q410071.0%3.22x1.05x–4.04x10066.5
2023 Q1–2025 Q413,59384.8%2.92x1.62x–4.53x8,681not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
80053 Blood test, comprehensive group of blood chemicals43387.3%9.02x31256
85025 Complete blood cell count (red cells, white blood cell, platelets), automated te38986.9%4.18x27653
99285 Emergency department visit with high level of medical decision making35887.4%3.14x32855
36415 Insertion of needle into vein for collection of blood sample31491.1%3.43x12873.5
84484 Troponin (protein) analysis, quantitative29289.0%2.81x20359
93005 Routine electrocardiogram (ECG) using at least 12 leads with tracing29291.1%2.75x20762.5
99284 Emergency department visit with moderate level of medical decision making25287.7%2.81x23949
87804 Detection test by immunoassay with direct visual observation for influenza virus22788.5%3.63x13971
71045 X-ray of chest, 1 view18989.9%2.82x13763
83735 Magnesium level18687.6%4.65x13054
87635 Amplifed DNA or RNA probe detection of severe acute respiratory syndrome coronav14589.7%2.08x10071
96374 Injection of drug or substance into vein12993.8%1.49x8762
70450 CT scan head or brain without contrast12288.5%3.76x9149.5
81003 Automated urinalysis test11885.6%1.86x8668.5
96375 Injection of additional new drug or substance into vein11891.5%2.88x5578.5
81001 Manual urinalysis test with examination using microscope, automated11486.0%1.78x8336
87040 Bacterial blood culture10287.3%5.56x7349
83690 Lipase (fat enzyme) level9487.2%5.30x6646
81025 Urine pregnancy test9090.0%6.18x6347
74177 CT scan of abdomen and pelvis with contrast8881.8%5.90x6254.5

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Arkansas · Hospitals and facilities in all states

FAQ

What is the Federal IDR provider win rate for hospitals and facilities in Arkansas?

In 2025 Q1–Q4, the provider or facility offer was selected in 87.8% of 7,221 determined dispute line items for hospitals and facilities in Arkansas. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for hospitals and facilities in Arkansas?

In 2025 Q1–Q4, the median prevailing offer was 3.12x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 1.70x to 4.78x (n = 5,004 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for hospitals and facilities in Arkansas?

In 2025 Q1–Q4, the median was 59 business days (n = 7,221 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR